hypertrichosis
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.07.2015
Juvéderm® VOLIFT™ Retouch extends the VYCROSS™ Collection
Allergan Symposium at the 13. AMWC in Monaco: The day long symposium under the guidance of Dr. Koenraad de Boulle from Belgium was dedicated to the motto „Achieving real expressions […]
27.09.2019
Interview with Rebecca Naumann: Cryolipolysis devices in comparison
When treating fat cells with cold it depends on the technique: The two leading suppliers in the German-speaking countries rely on certified medical technology. But what are the differences between […]

